[{"Year":"2018","Value":97,"Series":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) [3.b.1]"},{"Year":"2019","Value":98,"Series":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) [3.b.1]"},{"Year":"2018","Value":92,"Series":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) [3.b.1]"},{"Year":"2019","Value":92,"Series":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) [3.b.1]"},{"Year":"2018","Value":97,"Series":"Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) [3.b.1]"},{"Year":"2019","Value":98,"Series":"Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) [3.b.1]"}]